Open Multicentre Study of the Safety and Efficacy Against COVID-19 of Nirmatrelvir/Ritonavir in the Adult Population

Name: Open Multicentre Study of the Safety and Efficacy Against COVID-19 of Nirmatrelvir/Ritonavir in the Adult Population
Published: 2021
License: Public Domain

Promomed, LLC · 2021

ClinicalTrials.gov · Datasets · License: Public Domain · 2021

Open Source ↗

sars-cov-2

covid-19, nirmatrelvir/ritonavir, skayvira, sars-cov-2, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Open Multicentre Study of the Safety and Efficacy Against COVID-19 of Nirmatrelvir/Ritonavir in the Adult Population

Related documents